Product Code: PM2684
The global synthetic small molecule API market size is expected to reach USD 217.96 billion by 2030 according to a new study by Polaris Market Research. The report "Synthetic Small Molecule API Market Share, Size, Trends, Industry Analysis Report, By Application (Cardiology, Oncology, CNS and Neurology, Orthopaedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, Others); By Manufacturer; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The increasing demand for new small molecule-based drugs and pharmaceuticals worldwide has witnessed a steep increase in the production of synthetic APIs. Synthetic small molecules API provides versatility between dosage forms and has a smooth means of purification, making it more acceptable and increasing industry demand.
The increasing dominance of synthetic drugs in the pharmaceutical industry drives the industry demand for raw materials. Furthermore, improving existing products is expected to open up new avenues for therapeutics.
The ease of production associated with small molecules, as well as their high effectiveness, has driven the growth of the industry. The increased use of breakthrough technologies and the arrival of specialized pharmaceuticals are expected to cause excellent shifts in the small-scale production sector.
The COVID-19 pandemic eases market growth by encouraging players to expand their businesses to avoid geographical shortages. Studies for repurposing existing synthetic molecule drugs to treat SARS-CoV-2 infection are ongoing, which is expected to drive the growth of the market.
To meet industry demand, the players frequently engage in merger and acquisition activities. For instance, Novasep and PharmaZell collaborated in April 2022 to establish a leading technologically driven CDMO for complex specialty API production.
Synthetic Small Molecule API Market Report Highlights
The in-house accounted for the most significant shares due to the mounting number of manufacturers producing APIs to reduce the dependency on suppliers for chief raw materials.
The cardiology segment has the highest share in the industry due to the rising cases of cardiovascular conditions over the globe due to bad eating habits and a sedentary lifestyle.
North America accounts for the highest share, whereas the Asia Pacific estimates the fastest growth over the forecast.
The global market is highly competitive owing to the existence of large industry players with global presence AbbVie, Inc., Albemarle Corporation, Aurobindo Pharma, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Cipla, Inc., Dr. Reddy's Laboratories Ltd., Merck & Co., Inc., Rhizen Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc.
Polaris Market Research has segmented the Synthetic Small Molecule API market report based on type, functionality, end use and region:
Synthetic Small Molecule API, Manufacturer Outlook (Revenue - USD Billion, 2018 - 2030)
In-House
Outsourced
Synthetic Small Molecule API, Application Outlook (Revenue - USD Billion, 2018 - 2030)
Cardiology
Oncology
CNS and Neurology
Orthopedic
Endocrinology
Pulmonology
Gastroenterology
Nephrology
Ophthalmology
Others
Synthetic Small Molecule API, Regional Outlook (Revenue - USD Billion, 2018 - 2030)
North America
U.S
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Synthetic Small Molecule API Market Insights
- 4.1. Synthetic Small Molecule API Market - Industry Snapshot
- 4.2. Synthetic Small Molecule API Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increased outsourcing of API production
- 4.2.1.2. High demand for generic drugs
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High dependence on Asian nations for production
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Synthetic Small Molecule API Industry trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Synthetic Small Molecule API Market, by Manufacturer
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Synthetic Small Molecule API, by Manufacturer, 2018 - 2030 (USD Billion)
- 5.3. In-house
- 5.3.1. Global Synthetic Small Molecule API Market, by In-house, by Region, 2018 - 2030 (USD Billion)
- 5.4. Outsourced
- 5.4.1. Global Synthetic Small Molecule API Market, by Outsourced, by Region, 2018 - 2030 (USD Billion)
6. Global Synthetic Small Molecule API Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Synthetic Small Molecule API Market, by Application, 2018 - 2030 (USD Billion)
- 6.3. Cardiology
- 6.3.1. Global Synthetic Small Molecule API Market, by Cardiology, by Region, 2018 - 2030 (USD Billion)
- 6.4. Oncology
- 6.4.1. Global Synthetic Small Molecule API Market, by Oncology, by Region, 2018 - 2030 (USD Billion)
- 6.5. CNS and Neurology
- 6.5.1. Global Synthetic Small Molecule API Market, by CNS and Neurology, by Region, 2018 - 2030 (USD Billion)
- 6.6. Orthopaedic
- 6.6.1. Global Synthetic Small Molecule API Market, by Orthopaedic, by Region, 2018 - 2030 (USD Billion)
- 6.7. Endocrinology
- 6.7.1. Global Synthetic Small Molecule API Market, by Endocrinology, by Region, 2018 - 2030 (USD Billion)
- 6.8. Pulmonology
- 6.8.1. Global Synthetic Small Molecule API Market, by Pulmonology, by Region, 2018 - 2030 (USD Billion)
- 6.9. Gastroenterology
- 6.9.1. Global Synthetic Small Molecule API Market, by Gastroenterology, by Region, 2018 - 2030 (USD Billion)
- 6.10. Nephrology
- 6.10.1. Global Synthetic Small Molecule API Market, by Nephrology, by Region, 2018 - 2030 (USD Billion)
- 6.11. Ophthalmology
- 6.11.1. Global Synthetic Small Molecule API Market, by Ophthalmology, by Region, 2018 - 2030 (USD Billion)
- 6.12. Others
- 6.12.1. Global Synthetic Small Molecule API Market, by Others, by Region, 2018 - 2030 (USD Billion)
7. Global Synthetic Small Molecule API Market, by Geography
- 7.1. Key findings
- 7.2. Introduction
- 7.2.1. Synthetic Small Molecule API Market Assessment, By Geography, 2018 - 2030 (USD Billion)
- 7.3. Synthetic Small Molecule API Market - North America
- 7.3.1. North America: Synthetic Small Molecule API Market, by Application, 2018 - 2030 (USD Billion)
- 7.3.2. North America: Synthetic Small Molecule API Market, by Manufacturer, 2018 - 2030 (USD Billion)
- 7.3.3. Synthetic Small Molecule API Market - U.S.
- 7.3.3.1. U.S.: Synthetic Small Molecule API Market, by Application, 2018 - 2030 (USD Billion)
- 7.3.3.2. U.S.: Synthetic Small Molecule API Market, by Manufacturer, 2018 - 2030 (USD Billion)
- 7.3.4. Synthetic Small Molecule API Market - Canada
- 7.3.4.1. Canada: Synthetic Small Molecule API Market, by Application, 2018 - 2030 (USD Billion)
- 7.3.4.2. Canada: Synthetic Small Molecule API Market, by Manufacturer, 2018 - 2030 (USD Billion)
- 7.4. Synthetic Small Molecule API Market - Europe
- 7.4.1. Europe: Synthetic Small Molecule API Market, by Application, 2018 - 2030 (USD Billion)
- 7.4.2. Europe: Synthetic Small Molecule API Market, by Manufacturer, 2018 - 2030 (USD Billion)
- 7.4.3. Synthetic Small Molecule API Market - UK
- 7.4.3.1. UK: Synthetic Small Molecule API Market, by Application, 2018 - 2030 (USD Billion)
- 7.4.3.2. UK: Synthetic Small Molecule API Market, by Manufacturer, 2018 - 2030 (USD Billion)
- 7.4.4. Synthetic Small Molecule API Market - France
- 7.4.4.1. France: Synthetic Small Molecule API Market, by Application, 2018 - 2030 (USD Billion)
- 7.4.4.2. France: Synthetic Small Molecule API Market, by Manufacturer, 2018 - 2030 (USD Billion)
- 7.4.5. Synthetic Small Molecule API Market - Germany
- 7.4.5.1. Germany: Synthetic Small Molecule API Market, by Application, 2018 - 2030 (USD Billion)
- 7.4.5.2. Germany: Synthetic Small Molecule API Market, by Manufacturer, 2018 - 2030 (USD Billion)
- 7.4.6. Synthetic Small Molecule API Market - Italy
- 7.4.6.1. Italy: Synthetic Small Molecule API Market, by Application, 2018 - 2030 (USD Billion)
- 7.4.6.2. Italy: Synthetic Small Molecule API Market, by Manufacturer, 2018 - 2030 (USD Billion)
- 7.4.7. Synthetic Small Molecule API Market - Spain
- 7.4.7.1. Spain: Synthetic Small Molecule API Market, by Application, 2018 - 2030 (USD Billion)
- 7.4.7.2. Spain: Synthetic Small Molecule API Market, by Manufacturer, 2018 - 2030 (USD Billion)
- 7.4.8. Synthetic Small Molecule API Market - Netherlands
- 7.4.8.1. Netherlands: Synthetic Small Molecule API Market, by Application, 2018 - 2030 (USD Billion)
- 7.4.8.2. Netherlands: Synthetic Small Molecule API Market, by Manufacturer, 2018 - 2030 (USD Billion)
- 7.4.9. Synthetic Small Molecule API Market - Russia
- 7.4.9.1. Russia: Synthetic Small Molecule API Market, by Application, 2018 - 2030 (USD Billion)
- 7.4.9.2. Russia: Synthetic Small Molecule API Market, by Manufacturer, 2018 - 2030 (USD Billion)
- 7.5. Synthetic Small Molecule API Market - Asia Pacific
- 7.5.1. Asia Pacific: Synthetic Small Molecule API Market, by Application, 2018 - 2030 (USD Billion)
- 7.5.2. Asia Pacific: Synthetic Small Molecule API Market, by Manufacturer, 2018 - 2030 (USD Billion)
- 7.5.3. Synthetic Small Molecule API Market - China
- 7.5.3.1. China: Synthetic Small Molecule API Market, by Application, 2018 - 2030 (USD Billion)
- 7.5.3.2. China: Synthetic Small Molecule API Market, by Manufacturer, 2018 - 2030 (USD Billion)
- 7.5.4. Synthetic Small Molecule API Market - India
- 7.5.4.1. India: Synthetic Small Molecule API Market, by Application, 2018 - 2030 (USD Billion)
- 7.5.4.2. India: Synthetic Small Molecule API Market, by Manufacturer, 2018 - 2030 (USD Billion)
- 7.5.5. Synthetic Small Molecule API Market - Malaysia
- 7.5.5.1. Malaysia: Synthetic Small Molecule API Market, by Application, 2018 - 2030 (USD Billion)
- 7.5.5.2. Malaysia: Synthetic Small Molecule API Market, by Manufacturer, 2018 - 2030 (USD Billion)
- 7.5.6. Synthetic Small Molecule API Market - Japan
- 7.5.6.1. Japan: Synthetic Small Molecule API Market, by Application, 2018 - 2030 (USD Billion)
- 7.5.6.2. Japan: Synthetic Small Molecule API Market, by Manufacturer, 2018 - 2030 (USD Billion)
- 7.5.7. Synthetic Small Molecule API Market - Indonesia
- 7.5.7.1. Indonesia: Synthetic Small Molecule API Market, by Application, 2018 - 2030 (USD Billion)
- 7.5.7.2. Indonesia: Synthetic Small Molecule API Market, by Manufacturer, 2018 - 2030 (USD Billion)
- 7.5.8. Synthetic Small Molecule API Market - South Korea
- 7.5.8.1. South Korea: Synthetic Small Molecule API Market, by Application, 2018 - 2030 (USD Billion)
- 7.5.8.2. South Korea: Synthetic Small Molecule API Market, by Manufacturer, 2018 - 2030 (USD Billion)
- 7.6. Synthetic Small Molecule API Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Synthetic Small Molecule API Market, by Application, 2018 - 2030 (USD Billion)
- 7.6.2. Middle East & Africa: Synthetic Small Molecule API Market, by Manufacturer, 2018 - 2030 (USD Billion)
- 7.6.3. Synthetic Small Molecule API Market - Saudi Arabia
- 7.6.3.1. Saudi Arabia: Synthetic Small Molecule API Market, by Application, 2018 - 2030 (USD Billion)
- 7.6.3.2. Saudi Arabia: Synthetic Small Molecule API Market, by Manufacturer, 2018 - 2030 (USD Billion)
- 7.6.4. Synthetic Small Molecule API Market - UAE
- 7.6.4.1. UAE: Synthetic Small Molecule API Market, by Application, 2018 - 2030 (USD Billion)
- 7.6.4.2. UAE: Synthetic Small Molecule API Market, by Manufacturer, 2018 - 2030 (USD Billion)
- 7.6.5. Synthetic Small Molecule API Market - Israel
- 7.6.5.1. Israel: Synthetic Small Molecule API Market, by Application, 2018 - 2030 (USD Billion)
- 7.6.5.2. Israel: Synthetic Small Molecule API Market, by Manufacturer, 2018 - 2030 (USD Billion)
- 7.6.6. Synthetic Small Molecule API Market - South Africa
- 7.6.6.1. South Africa: Synthetic Small Molecule API Market, by Application, 2018 - 2030 (USD Billion)
- 7.6.6.2. South Africa: Synthetic Small Molecule API Market, by Manufacturer, 2018 - 2030 (USD Billion)
- 7.7. Synthetic Small Molecule API Market - Latin America
- 7.7.1. Latin America: Synthetic Small Molecule API Market, by Application, 2018 - 2030 (USD Billion)
- 7.7.2. Latin America: Synthetic Small Molecule API Market, by Manufacturer, 2018 - 2030 (USD Billion)
- 7.7.3. Synthetic Small Molecule API Market - Mexico
- 7.7.3.1. Mexico: Synthetic Small Molecule API Market, by Application, 2018 - 2030 (USD Billion)
- 7.7.3.2. Mexico: Synthetic Small Molecule API Market, by Manufacturer, 2018 - 2030 (USD Billion)
- 7.7.4. Synthetic Small Molecule API Market - Brazil
- 7.7.4.1. Brazil: Synthetic Small Molecule API Market, by Application, 2018 - 2030 (USD Billion)
- 7.7.4.2. Brazil: Synthetic Small Molecule API Market, by Manufacturer, 2018 - 2030 (USD Billion)
- 7.7.5. Synthetic Small Molecule API Market - Argentina
- 7.7.5.1. Argentina: Synthetic Small Molecule API Market, by Application, 2018 - 2030 (USD Billion)
- 7.7.5.2. Argentina: Synthetic Small Molecule API Market, by Manufacturer, 2018 - 2030 (USD Billion)
8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
- 9.1. AbbVie, Inc
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. Albemarle Corporation
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. Aurobindo Pharma
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Boehringer Ingelheim International GmbH
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. Bristol-Myers Squibb Company
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. Cipla, Inc
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Dr. Reddy's Laboratories Ltd
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Merck & Co., Inc
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. Rhizen Pharmaceuticals
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Sun Pharmaceutical Industries Ltd
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
- 9.11. Teva Pharmaceutical Industries Ltd
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
- 9.12. Viatris Inc
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development